Search research articles
Contact Us
Filters
Showing results (51-60 of 97) with videos related to
Page
of 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
September 15, 1992
In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor
S E Karp, P Hwu, A Farber, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 15, 1995
IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases
V Bronte, K Tsung, J B Rao, et al.
Journal of Immunological Methods
|
August 6, 1998
Generation of polyclonal rabbit antisera to mouse melanoma associated antigens using gene gun immunization
D R Surman, K R Irvine, E P Shulman, et al.
Journal of the National Cancer Institute
|
November 15, 1997
Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors
K R Irvine, R S Chamberlain, E P Shulman, et al.
Gene Therapy
|
September 14, 2012
Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy
L Zhang, Z Yu, P Muranski, et al.
Cancer Immunology, Immunotherapy : CII
|
October 1, 1993
Retroviral transduction of interferon-gamma cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor
E Shiloni, S E Karp, M C Custer, et al.
Cancer Research
|
April 5, 2000
Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice
A L Feldman, N P Restifo, H R Alexander, et al.
Cancer Research
|
February 10, 2000
Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo
V Bronte, E Apolloni, R Ronca, et al.
The Journal of Experimental Medicine
|
February 1, 1993
Identification of human cancers deficient in antigen processing
N P Restifo, F Esquivel, Y Kawakami, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 26, 1999
Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model
H L Kaufman, J B Rao, K R Irvine, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 97) with videos related to
Sort By:
Page
of 10
Journal of Immunology (Baltimore, Md. : 1950)
|
September 15, 1992
In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor
S E Karp, P Hwu, A Farber, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 15, 1995
IL-2 enhances the function of recombinant poxvirus-based vaccines in the treatment of established pulmonary metastases
V Bronte, K Tsung, J B Rao, et al.
Journal of Immunological Methods
|
August 6, 1998
Generation of polyclonal rabbit antisera to mouse melanoma associated antigens using gene gun immunization
D R Surman, K R Irvine, E P Shulman, et al.
Journal of the National Cancer Institute
|
November 15, 1997
Enhancing efficacy of recombinant anticancer vaccines with prime/boost regimens that use two different vectors
K R Irvine, R S Chamberlain, E P Shulman, et al.
Gene Therapy
|
September 14, 2012
Inhibition of TGF-β signaling in genetically engineered tumor antigen-reactive T cells significantly enhances tumor treatment efficacy
L Zhang, Z Yu, P Muranski, et al.
Cancer Immunology, Immunotherapy : CII
|
October 1, 1993
Retroviral transduction of interferon-gamma cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor
E Shiloni, S E Karp, M C Custer, et al.
Cancer Research
|
April 5, 2000
Antiangiogenic gene therapy of cancer utilizing a recombinant adenovirus to elevate systemic endostatin levels in mice
A L Feldman, N P Restifo, H R Alexander, et al.
Cancer Research
|
February 10, 2000
Genetic vaccination with "self" tyrosinase-related protein 2 causes melanoma eradication but not vitiligo
V Bronte, E Apolloni, R Ronca, et al.
The Journal of Experimental Medicine
|
February 1, 1993
Identification of human cancers deficient in antigen processing
N P Restifo, F Esquivel, Y Kawakami, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 26, 1999
Interleukin-10 enhances the therapeutic effectiveness of a recombinant poxvirus-based vaccine in an experimental murine tumor model
H L Kaufman, J B Rao, K R Irvine, et al.
Page
of 10